TIAA Wealth Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
TIAA Wealth Investment Management's BMY Position: Q2 2026 in Review
TIAA Wealth Investment Management increased its Bristol-Myers Squibb (BMY) stake by 4.3% in Q2 2026, buying an estimated $35.4K and bringing the position to 14,907 shares worth $860K. The position accounts for 0.01% of the portfolio, ranked #195.
TIAA Wealth Investment Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $866K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- TIAA Wealth Investment Management held 14,907 shares of Bristol-Myers Squibb worth $860K as of Q2 2026.
- TIAA Wealth Investment Management bought 617 Bristol-Myers Squibb shares in Q2 2026, an estimated $35.4K.
- Bristol-Myers Squibb made up 0.01% of TIAA Wealth Investment Management's portfolio in Q2 2026, its #195 holding.
- TIAA Wealth Investment Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- TIAA Wealth Investment Management's Bristol-Myers Squibb position peaked at $866K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on TIAA Wealth Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.